VALIANT LABORATORIES
|
The Current P/S Ratio of VALIANT LABORATORIES is 2.13.
| Share Price | ₹119.9 | Oct 09,2026 |
| Market Cap | ₹651.1 Cr | |
| Sales-TTM | ₹305.9 Cr | TTM-Consolidated Results |
| Price/Sales | 2.13x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VALIANT LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹651.1 Cr] as on Oct 09,2026
(/) Sales [ ₹305.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.13x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay '2.13 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VALIANT LABORATORIES !
The chart below summarizes the trend in P/S Ratio of VALIANT LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of VALIANT LABORATORIES
PS Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 1.99x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 2.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 3.47x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does VALIANT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VALIANT LABORATORIES | 305.9 | 2.13 | 651.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.04 | 421,539.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.05 | 247,576.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.27 | 177,251.0 |
| CIPLA LTD | 28,324.4 | 3.72 | 105,290.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.00 | 99,752.6 |
| MANKIND PHARMA LTD | 14,737.9 | 6.64 | 97,850.4 |
| LUPIN LTD | 29,966.6 | 2.99 | 89,628.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.89 | 111,232.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.78 | 97,014.5 |
| LAURUS LABS LTD | 7,269.6 | 15.10 | 109,797.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VALIANT LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.13x |
| Max industry PS | 22.05x |
| Median industry PS | 3.89x |
| Average industry PS | 7.33x |
You may also like the below Video Courses